Migraine prophylaxis

Migraine is a common and disabling primary headache disorder and one of the conditions most frequently seen in primary care. 

After completing this module, clinicians will be able to: 

• Describe the underlying pathophysiology of migraine and understand how this informs treatment selection. 
• Identify when to start migraine prophylaxis and tailor therapy according to comorbidities, contraindications, and patient preferences. 
• Compare the efficacy, tolerability, and practical use of established oral agents with newer options such as CGRP monoclonal antibodies and gepants. 
• Apply current evidence to the prescribing, monitoring, and discontinuation of prophylactic medications, with attention to safety considerations (e.g. reproductive status, co-morbidities, constipation). 
• Integrate lifestyle, supplements and non-pharmacological measures to optimise outcomes and reduce the risk of medication overuse. 

Acknowledgements

Content created by Dr Danuta Amelung, BHB, MbChB, FRNZCGP, AFRACMA, Dip. Paed, PGCertWHlth, PGDipTrvMed, with review by Bary Snow, Neurologist.

This eLearning is sponsored with an unrestricted educational grant from AbbVie Pty Ltd.